Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance

Arthritis Research and Therapy

Volumn 14, Issue 2, 2012, Pages

  Kiyama, Kazuhiro ^a   Kawabata, Daisuke ^a   Hosono, Yuji ^a   Kitagori, Koji ^a   Yukawa, Naoichiro ^a   Yoshifuji, Hajime ^a   Omura, Koichiro ^a   Fujii, Takao ^a   Mimori, Tsuneyo ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; APRIL PROTEIN; B CELL ACTIVATING FACTOR; GLUCOCORTICOID; IMMUNOGLOBULIN G4; PREDNISOLONE; RHEUMATOID FACTOR; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; TNFSF13B PROTEIN, HUMAN;

ADULT; AGAMMAGLOBULINEMIA; AGED; ARTICLE; BIOPSY; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; FEMALE; HISTOLOGY; HUMAN; INTERSTITIAL NEPHRITIS; INTERSTITIAL PNEUMONIA; LYMPHADENOPATHY; MALE; MIKULICZ DISEASE; ORBIT TUMOR; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PSEUDOTUMOR; RETROPERITONEAL FIBROSIS; SEROLOGY; SIALOADENITIS; SJOEGREN SYNDROME; TREATMENT DURATION; BLOOD; MIDDLE AGED;

ADULT; AGED; B-CELL ACTIVATING FACTOR; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SJOGREN'S SYNDROME; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84859932231     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3810     Document Type: Article

References (47)

1. Masaki Y, Kurose N, Umehara H. IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J Clin Exp Hematop 2011, 51:13-20. 10.3960/jslrt.51.13, 21628856.
2. Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, Takahashi H, Shinomura Y, Imai K, Saeki T, Azumi A, Nakada S, Sugiyama E, Matsui S, Origuchi T, Nishiyama S, Nishimori I, Nojima T, Yamada K, Kawano M, Zen Y, Kaneko M, Miyazaki K, Tsubota K, Eguchi K, Tomoda K, Sawaki T, Kawanami T, Tanaka M, Fukushima T, Sugai S, Umehara H. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009, 68:1310-1315. 10.1136/ard.2008.089169, 18701557.
3. Okazaki K, Uchida K, Miyoshi H, Ikeura T, Takaoka M, Nishio A. Recent concepts of autoimmune pancreatitis and IgG4-related disease. Clin Rev Allergy Immunol 2011, 41:126-138. 10.1007/s12016-010-8214-2, 21170607.
4. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D. A novel clinical entity, IgG4-related disease (IgG4-RD): general concept and details. Mod Rheumatol 2011, 22:1-14. 3278618, 21881964.
5. Deshpande V, Chicano S, Finkelberg D, Selig MK, Mino-Kenudson M, Brugge WR, Colvin RB, Lauwers GY. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol 2006, 30:1537-1545. 10.1097/01.pas.0000213331.09864.2c, 17122509.
6. Otsuki M, Chung JB, Okazaki K, Kim MH, Kamisawa T, Kawa S, Park SW, Shimosegawa T, Lee K, Ito T, Nishimori I, Notohara K, Naruse S, Ko SB, Kihara Y. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008, 43:403-408. 10.1007/s00535-008-2205-6, 18600383.
7. Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, Clain JE, Pearson RK, Petersen BT, Vege SS, Farnell MB. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006, 4:1010-1016; quiz 1934. 10.1016/j.cgh.2006.05.017, 16843735.
8. Takuma K, Kamisawa T, Igarashi Y. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis. Curr Opin Rheum 2011, 23:80-87.
9. Kitagawa S, Zen Y, Harada K, Sasaki M, Sato Y, Minato H, Watanabe K, Kurumaya H, Katayanagi K, Masuda S, Niwa H, Tsuneyama K, Saito K, Haratake J, Takagawa K, Nakanuma Y. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner's tumor). Am J Surg Pathol 2005, 29:783-791. 10.1097/01.pas.0000164031.59940.fc, 15897744.
10. Dahlgren M, Khosroshahi A, Nielsen GP, Deshpande V, Stone JH. Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res 2010, 62:1312-1318.
11. Stone JH, Khosroshahi A, Hilgenberg A, Spooner A, Isselbacher EM, Stone JR. IgG4-related systemic disease and lymphoplasmacytic aortitis. Arthritis Rheum 2009, 60:3139-3145. 10.1002/art.24798, 19790067.
12. Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, Yamamoto M, Takahashi H, Matsui S, Nakada S, Origuchi T, Hirabayashi A, Homma N, Tsubata Y, Takata T, Wada Y, Saito A, Fukase S, Ishioka K, Miyazaki K, Masaki Y, Umehara H, Sugai S, Narita I. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int 2010, 78:1016-1023. 10.1038/ki.2010.271, 20720530.
13. Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 2011, 23:88-94. 10.1097/BOR.0b013e3283412f7c, 21037477.
14. Hamano H, Kawa S, Ochi Y, Unno H, Shiba N, Wajiki M, Nakazawa K, Shimojo H, Kiyosawa K. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002, 359:1403-1404. 10.1016/S0140-6736(02)08359-9, 11978339.
15. Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, Matsushima Y, Katamura K, Ohmori K, Chiba T. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000, 118:573-581. 10.1016/S0016-5085(00)70264-2, 10702209.
16. Nishi H, Tojo A, Onozato ML, Jimbo R, Nangaku M, Uozaki H, Hirano K, Isayama H, Omata M, Kaname S, Fujita T. Anti-carbonic anhydrase II antibody in autoimmune pancreatitis and tubulointerstitial nephritis. Nephrol Dial Transplant 2007, 22:1273-1275. 10.1093/ndt/gfl672, 17138573.
17. Endo T, Takizawa S, Tanaka S, Takahashi M, Fujii H, Kamisawa T, Kobayashi T. Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes. Diabetes 2009, 58:732-737. 2646073, 19001184.
18. Asada M, Nishio A, Uchida K, Kido M, Ueno S, Uza N, Kiriya K, Inoue S, Kitamura H, Ohashi S, Tamaki H, Fukui T, Matsuura M, Kawasaki K, Nishi T, Watanabe N, Nakase H, Chiba T, Okazaki K. Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis. Pancreas 2006, 33:20-26. 10.1097/01.mpa.0000226881.48204.fd, 16804408.
19. Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M, Benini L, Vantini I, Corrocher R, Puccetti A. Identification of a novel antibody associated with autoimmune pancreatitis. N Eng J Med 2009, 361:2135-2142.
20. Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, Nakanuma Y. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007, 45:1538-1546. 10.1002/hep.21697, 17518371.
21. Zen Y, Nakanuma Y. Pathogenesis of IgG4-related disease. Curr Opin Rheumatol 2011, 23:114-118. 10.1097/BOR.0b013e3283412f4a, 21045701.
22. Mackay F, Schneider P, Rennert P, Browning J. BAFF AND APRIL: a tutorial on B cell survival. Ann Rev Immunol 2003, 21:231-264.
23. Tangye SG, Bryant VL, Cuss AK, Good KL. BAFF, APRIL and human B cell disorders. Semin Immunol 2006, 18:305-317. 10.1016/j.smim.2006.04.004, 16916610.
24. Lopez-Fraga M, Fernandez R, Albar JP, Hahne M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep 2001, 2:945-951. 10.1093/embo-reports/kve198, 1084076, 11571266.
25. Liu Z, Davidson A. BAFF and selection of autoreactive B cells. Trends Immunol 2011, 32:388-394. 10.1016/j.it.2011.06.004, 21752714.
26. Mackay F, Tangye SG. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr Opin Pharmacol 2004, 4:347-354. 10.1016/j.coph.2004.02.009, 15251127.
27. Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol 2009, 9:491-502. 10.1038/nri2572, 19521398.
28. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J, Browning JL. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999, 190:1697-1710. 10.1084/jem.190.11.1697, 2195729, 10587360.
29. Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D, Morelli A, Ferraccioli G. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol 2008, 35:1256-1264.
30. Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Xu D, Roschke V, Wu Y, Baker KP, Hilbert DM. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum 2003, 48:3475-3486. 10.1002/art.11354, 14673998.
31. Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann Rheum Dis 2003, 62:168-171. 10.1136/ard.62.2.168, 1754442, 12525388.
32. Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. J Clin Immunol 2005, 25:189-201. 10.1007/s10875-005-4091-5, 15981083.
33. Krystufkova O, Vallerskog T, Helmers SB, Mann H, Putova I, Belacek J, Malmstrom V, Trollmo C, Vencovsky J, Lundberg IE. Increased serum levels of B cell-activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Ann Rheum Dis 2009, 68:836-843. 10.1136/ard.2008.091405, 18628284.
34. Matsushita T, Hasegawa M, Yanaba K, Kodera M, Takehara K, Sato S. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes. Arthritis Rheum 2006, 54:192-201. 10.1002/art.21526, 16385515.
35. Kang JS, Yoon YD, Ahn JH, Kim SC, Kim KH, Kim HM, Moon EY. B cell-activating factor is a novel diagnosis parameter for asthma. Int Arch Allergy Immunol 2006, 141:181-188. 10.1159/000094897, 16899986.
36. Jee HM, Kim KW, Hong JY, Sohn MH, Kim KE. Increased serum B cell-activating factor level in children with atopic dermatitis. Clin Exp Dermatol 2010, 35:593-598.
37. Stein JV, Lopez-Fraga M, Elustondo FA, Carvalho-Pinto CE, Rodriguez D, Gomez-Caro R, De Jong J, Martinez AC, Medema JP, Hahne M. APRIL modulates B and T cell immunity. J Clin Invest 2002, 109:1587-1598. 151011, 12070306.
38. Varfolomeev E, Kischkel F, Martin F, Seshasayee D, Wang H, Lawrence D, Olsson C, Tom L, Erickson S, French D, Schow P, Grewal IS, Ashkenazi A. APRIL-deficient mice have normal immune system development. Mol Cell Biol 2004, 24:997-1006. 10.1128/MCB.24.3.997-1006.2004, 321448, 14729948.
39. Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, Mizoguchi E, Geha RS. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA 2004, 101:3903-3908. 10.1073/pnas.0307348101, 374342, 14988498.
40. Koyama T, Tsukamoto H, Miyagi Y, Himeji D, Otsuka J, Miyagawa H, Harada M, Horiuchi T. Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann Rheum Dis 2005, 64:1065-1067. 10.1136/ard.2004.022491, 1755547, 15576416.
41. Thangarajh M, Masterman T, Rot U, Duvefelt K, Brynedal B, Karrenbauer VD, Hillert J. Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis. J Neuroimmunol 2005, 167:210-214. 10.1016/j.jneuroim.2005.06.024, 16087247.
42. Szodoray P, Jonsson R. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjogren's syndrome. Scand J Immunol 2005, 62:421-428. 10.1111/j.1365-3083.2005.01688.x, 16305638.
43. Yamada K, Kawano M, Inoue R, Hamano R, Kakuchi Y, Fujii H, Matsumura M, Zen Y, Takahira M, Yachie A, Yamagishi M. Clonal relationship between infiltrating immunoglobulin G4 (IgG4)-positive plasma cells in lacrimal glands and circulating IgG4-positive lymphocytes in Mikulicz's disease. Clin Exp Immunol 2008, 152:432-439. 10.1111/j.1365-2249.2008.03651.x, 2453205, 18422733.
44. Yamada T, Zhang K, Yamada A, Zhu D, Saxon A. B lymphocyte stimulator activates p38 mitogen-activated protein kinase in human Ig class switch recombination. Am J Respir Cell Mol Biol 2005, 32:388-394. 10.1165/rcmb.2004-0317OC, 15668322.
45. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002, 3:822-829.
46. Yamanishi H, Kumagi T, Yokota T, Azemoto N, Koizumi M, Kobayashi Y, Abe M, Murakami H, Hiasa Y, Matsuura B, Kawamoto H, Yamamoto K, Onji M. Clinical significance of B cell-activating factor in autoimmune pancreatitis. Pancreas 2011, 40:840-845. 10.1097/MPA.0b013e3182143b10, 21747319.
47. Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Roschke V, Wu Y, Baker KP, Hilbert DM. Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 2004, 63:1096-1103. 10.1136/ard.2003.018663, 1755113, 15308519.